You are here: Industry Insights > Louisiana

News List

Louisiana's 'Netflix' deal for hepatitis C drugs wins bids from AbbVie, Gilead and Merck fiercepharma
March 11, 2019
States across the U.S. have taken on high drug prices with new laws, proposals and Medicaid rules, many of them unpopular with the pharma industry. Not so in Louisiana, where a “Netflix” payment model for hepatitis C drugs has top players eager to partici
Drug companies interested in Louisiana hepatitis C drug plan firstwordpharma
March 03, 2019
Louisiana's Department of Health announced that Merck & Co., AbbVie and Gilead Sciences are interested in the state's plan to use a Netflix-style subscription model to buy access to hepatitis C drugs for Medicaid patients and prisoners, as reported in the
State of Louisiana Pharmacy Board Selects Nine Pharmacies to Dispense Medical Cannabis americanpharmaceuticalreview
August 24, 2018
GB Sciences, with the first cannabis crop now in production at their high-tech 36,000 square-foot grow facility in Baton Rouge, and teams from GB Sciences and the LSU AgCenter are working closely with Louisiana pharmacists who will serve patients starting
Louisiana seeking comments on 'Netflix' model for hepatitis C drugs fiercepharma
August 17, 2018
As drug costs continue to capture national attention and the Trump Administration tries its hand at providing relief, Louisiana has rolled out a proposal it thinks can help solve the state afford the high cost of hepatitis C drugs.